Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
RETINA
Publication-derived

Retinal 2D Cell Cultures for Disease Modelling (2012) (RT-DS-12)

Source Mellough et al., 2012 · Institute of Genetic Medicine, Newcastle University · DOI

Duration: 60 days Cell source: Human hESC (H9 line), Human iPSC derived from neonatal dermal skin fibroblasts Full SOP · 5 phases · QC included
Disease modelling
RT-DS-12 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening and Long-Term Culture (LV-DS-19)

Source Akbari et al., 2019 · Izmir Biomedicine and Genome Center / Dokuz Eylul University · DOI

Duration: 24 days Cell source: Human iPSC, Patient-Derived iPSC (Citrullinemia type 1) Full SOP · 6 phases · QC included
Drug screening
LV-DS-19 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids with Single-Cell Profiling (IN-DS-20)

Source Ringel et al., 2020 · Institute of Molecular Health Sciences, ETH Zurich, and Department of Pharmacology and Toxicology, University of Zurich · DOI

Duration: 30 days Cell source: Human intestinal epithelial cells (derived from patient biopsies) Full SOP · 8 phases · QC included
Drug screening
IN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Cerebral Organoids for Infection Studies (2022) (BN-DS-22)

Source Gumbs et al., 2022 · University Medical Center Utrecht, Department of Medical Microbiology · DOI

Duration: 28 days Cell source: Human iPSC Full SOP · 8 phases · QC included
Disease modelling
BN-DS-22 Full SOP with Academic or a plan
LIVER
Publication-derived

Sepsis Liver Organoids (LV-DS-24)

Source Li et al., 2024 · The University of Tokyo, Institute of Medical Science · DOI

Duration: 19 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
LV-DS-24 Full SOP with Academic or a plan
OTHER
Publication-derived

Biliary Tract Carcinoma Tumouroids

Source Saito et al., 2019 · Keio University Faculty of Pharmacy, Division of Pharmacotherapeutics · DOI

Duration: 365 days Cell source: Patient-Derived Surgical Tissue (Intrahepatic Cholangiocarcinoma, Gallbladder Cancer, Neuroendocrine Carcinoma) Full SOP · 6 phases · QC included
Drug screening
Full SOP with Academic or a plan
BRAIN
Publication-derived

Chronic Stroke Cortical Organoids (BN-DS-25)

Source Wang et al., 2025 · University of Maryland School of Medicine · DOI

Duration: 56 days Cell source: Human iPSC Full SOP · 11 phases · QC included
Disease modelling
BN-DS-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Disease Modelling with Interneurons (2017) (BN-DS-17)

Source Bagley et al., 2017 · Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria · DOI

Duration: 80 days Cell source: Human iPSC Full SOP · 7 phases · QC included
Disease modelling
BN-DS-17 Full SOP with Academic or a plan
BRAIN
Publication-derived

Schizophrenia Brain 2D Cell Cultures (BN-DS-14)

Source Yoon et al., 2014 · Institute for Cell Engineering, Johns Hopkins University School of Medicine · DOI

Duration: 22 days Cell source: Patient-Derived iPSC (15q11.2 microdeletion schizophrenia risk carriers) Full SOP · 10 phases · QC included
Disease modelling
BN-DS-14 Full SOP with Academic or a plan
BRAIN
Publication-derived

Cryptococcal Meningitis Cerebral Organoids (BN-DS-25)

Source Harding et al., 2025 · Massachusetts General Hospital, Harvard Medical School · DOI

Duration: 35 days Cell source: Human ESC (WIBR3) Full SOP · 8 phases · QC included
Disease modelling
BN-DS-25 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Organoids for Disease Modelling (2016) (RT-DS-16)

Source Lowe et al., 2016 · Albert Einstein College of Medicine, Department of Genetics and Department of Ophthalmology and Visual Sciences, Bronx, NY 10461, USA · DOI

Duration: 187 days Cell source: Human ESC (H1 hESC, hiPSC) Full SOP · 5 phases · QC included
Disease modelling
RT-DS-16 Full SOP with Academic or a plan
PANCREAS
Publication-derived

COVID-19 Pancreatic Organoids (PN-DS-20)

Source Yang et al., 2020 · Weill Cornell Medicine · DOI

Duration: 48 days Cell source: Human iPSC and Human ESC Full SOP · 8 phases · QC included
Disease modelling
PN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Brain Models (2021) (BN-DS-21)

Source Wang et al., 2021 · Beckman Research Institute of City of Hope · DOI

Duration: 144 days Cell source: Human iPSC Full SOP · 11 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
PANCREAS
Publication-derived

Cystic Fibrosis Pancreatic 2D Cell Cultures (PN-FI-16)

Source Simsek et al., 2016 · Weill Cornell Medical College · DOI

Duration: 30 days Cell source: Human ESC and Patient-Derived iPSC (Cystic Fibrosis) Full SOP · 7 phases · QC included
Drug screening
PN-FI-16 Full SOP with Academic or a plan
BRAIN
Publication-derived

Bipolar Disorder Brain Organoids for Developmental Studies (BN-DS-21)

Source Tran et al., 2021 · University of Michigan, Michigan Medicine · DOI

Duration: 90 days Cell source: Patient-Derived iPSC (Bipolar Disorder), Human iPSC (Control) Full SOP · 9 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Bioprinted and Engineered Tissues for Drug Screening

Source Saheli et al. · Royan Institute for Stem Cell Biology and Technology and Shahid Beheshti University of Medical Sciences, Tehran, Iran · DOI

Duration: 10 days Cell source: Human hepatocarcinoma cells (Huh7) with human bone marrow-derived mesenchymal stem cells (MSCs) and human umbilical vein endothelial cells (HUVECs) Full SOP · 4 phases · QC included
Drug screening
Full SOP with Academic or a plan
GASTRIC
Publication-derived

Gastric Organoids for Drug Screening (GS-DS-14)

Source McCracken et al., 2014 · Cincinnati Children's Hospital Medical Center · DOI

Duration: 34 days Cell source: Human ESC (H1, H9), Human iPSC (from neonatal foreskin fibroblasts) Full SOP · 6 phases · QC included
Drug screening
GS-DS-14 Full SOP with Academic or a plan
SKIN
Publication-derived

Skin Organoids for Regenerative Medicine (2024) (SK-TX-24)

Source Ahmed et al., 2024 · Frazer Institute, Faculty of Medicine, The University of Queensland · DOI

Duration: 120 days Cell source: Human iPSC Full SOP · 4 phases · QC included
Regenerative medicine
SK-TX-24 Full SOP with Academic or a plan
GASTRIC
Publication-derived

Gastric Adenocarcinoma Tumouroids for Drug Screening (GS-DS-19)

Source Seidlitz et al., 2019 · University Hospital Carl Gustav Carus, Technische Universität Dresden · DOI

Duration: 35 days Cell source: Human gastric cancer tissue (patient-derived) Full SOP · 12 phases · QC included
Drug screening
GS-DS-19 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids (2015) (IN-CA-15)

Source Drost et al., 2015 · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht · DOI

Duration: 196 days Cell source: Human intestinal stem cells (normal duodenal and colon tissue) Full SOP · 8 phases · QC included
Disease modelling
IN-CA-15 Full SOP with Academic or a plan
BRAIN
Publication-derived

Traumatic Brain Injury Organoids (BN-DS-24)

Source Lai et al., 2024 · Keck School of Medicine, University of Southern California · DOI

Duration: 62 days Cell source: Human iPSC, Patient-derived iPSC (C9ORF72 ALS/FTD) Full SOP · 9 phases · QC included
Disease modelling
BN-DS-24 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatocellular Carcinoma Liver Bioprinted and Engineered Tissues (LV-DS-21)

Source Oz et al., 2021 · Izmir Biomedicine and Genome Center; Dokuz Eylul University · DOI

Duration: 16 days Cell source: HCC cell lines (Hep3B, Huh7, HepG2, SNU398, SNU449, SNU475) Full SOP · 7 phases · QC included
Disease modelling
LV-DS-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Midbrain Organoids (2020, No. 2) (BN-DS-20)

Source Nickels et al., 2020 · Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg · DOI

Duration: 38 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatoblastoma Liver Reference Datasets (LV-DS-23)

Source Clavería-Cabello et al., 2023 · CIMA, University of Navarra, Pamplona, Spain · DOI

Duration: 63 days Cell source: Primary HB cell lines, established HB cell lines (HuH6, HepT1, HepG2), patient-derived xenograft cells Full SOP · 16 phases · QC included
Drug screening
LV-DS-23 Full SOP with Academic or a plan